Chemotherapy-Induced Nausea and Vomiting.
作者信息
Rapoport Bernardo Leon, Molasiotis Alexander, Raftopoulos Haralambos, Roila Fausto
机构信息
The Medical Oncology Center of Rosebank, Saxonwold, Johannesburg 2196, South Africa.
School of Nursing, The Hong Kong Polytechnic University, Hong Kong.
出版信息
Biomed Res Int. 2015;2015:457326. doi: 10.1155/2015/457326. Epub 2015 Sep 6.
Abstract
摘要
相似文献
1
Chemotherapy-Induced Nausea and Vomiting.化疗引起的恶心和呕吐
Biomed Res Int. 2015;2015:457326. doi: 10.1155/2015/457326. Epub 2015 Sep 6.
2
Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.化疗引起的恶心和呕吐：影响临床实践的止吐试验
J Oncol Pharm Pract. 2010 Dec;16(4):233-44. doi: 10.1177/1078155209354655. Epub 2010 Jan 19.
3
Pharmacological mechanisms of 5-HT₃ and tachykinin NK₁ receptor antagonism to prevent chemotherapy-induced nausea and vomiting.预防化疗引起的恶心和呕吐的 5-HT₃ 和 tachykinin NK₁ 受体拮抗作用的药理学机制。
Eur J Pharmacol. 2012 Jun 5;684(1-3):1-7. doi: 10.1016/j.ejphar.2012.01.046. Epub 2012 Mar 9.
4
Aprepitant (EMEND): the role of substance P in nausea and vomiting.阿瑞匹坦（意美）：P物质在恶心和呕吐中的作用。
J Pain Palliat Care Pharmacother. 2005;19(3):31-9.
5
6
Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.帕洛诺司琼与第一代 5-HT3 受体拮抗剂治疗化疗致恶心呕吐的疗效和安全性比较：一项荟萃分析。
Eur J Cancer Care (Engl). 2013 Jan;22(1):41-50. doi: 10.1111/j.1365-2354.2012.01353.x. Epub 2012 Apr 22.
7
Emerging treatments in chemotherapy-induced nausea and vomiting.化疗引起的恶心和呕吐的新兴治疗方法。
Clin Adv Hematol Oncol. 2013 Feb;11(2 Suppl 1):1-18; quiz 2 p following 18.
8
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.化疗引起的恶心和呕吐的预防性止吐治疗
N Engl J Med. 2016 Apr 7;374(14):1356-67. doi: 10.1056/NEJMra1515442.
9
Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.基于发病机制的化疗所致恶心和呕吐的治疗——两种新药
J Support Oncol. 2003 Jul-Aug;1(2):89-103.
10
Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.阿瑞匹坦联合帕洛诺司琼和地塞米松预防接受多日顺铂化疗的患者化疗引起的恶心和呕吐。
Intern Med J. 2013 Jan;43(1):73-6. doi: 10.1111/j.1445-5994.2011.02637.x.
引用本文的文献
1
Clinical pattern and drug-related problems among colorectal cancer patients at oncology center in Ethiopia: A hospital-based study.埃塞俄比亚肿瘤中心结直肠癌患者的临床模式及药物相关问题：一项基于医院的研究。
SAGE Open Med. 2022 Oct 17;10:20503121221131691. doi: 10.1177/20503121221131691. eCollection 2022.
2
The Practical Consideration of Poliovirus as an Oncolytic Virotherapy.将脊髓灰质炎病毒作为溶瘤病毒疗法的实际考量
Am J Virol. 2016;5(1):1-7. doi: 10.3844/ajvsp.2016.1.7. Epub 2016 Mar 3.
3
Comparative effectiveness of ramosetron for preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis.雷莫司琼预防化疗引起的恶心和呕吐的比较效果：一项系统评价和荟萃分析。
Eur J Clin Pharmacol. 2016 Nov;72(11):1289-1301. doi: 10.1007/s00228-016-2100-7. Epub 2016 Aug 15.
本文引用的文献
1
Antiemetics: American Society of Clinical Oncology clinical practice guideline update.止吐药：美国临床肿瘤学会临床实践指南更新。
J Clin Oncol. 2011 Nov 1;29(31):4189-98. doi: 10.1200/JCO.2010.34.4614. Epub 2011 Sep 26.
2
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.MASCC和ESMO预防化疗及放疗引起的恶心和呕吐指南更新：佩鲁贾共识会议结果
Ann Oncol. 2010 May;21 Suppl 5:v232-43. doi: 10.1093/annonc/mdq194.
3
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.口服神经激肽-1拮抗剂阿瑞匹坦预防化疗引起的恶心和呕吐：一项针对接受高剂量顺铂治疗患者的多国、随机、双盲、安慰剂对照试验——阿瑞匹坦方案052研究组
J Clin Oncol. 2003 Nov 15;21(22):4112-9. doi: 10.1200/JCO.2003.01.095. Epub 2003 Oct 14.
4
Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.在标准止吐治疗中添加神经激肽1受体拮抗剂阿瑞匹坦可改善对化疗引起的恶心和呕吐的控制。拉丁美洲一项随机、双盲、安慰剂对照试验的结果。
Cancer. 2003 Jun 15;97(12):3090-8. doi: 10.1002/cncr.11433.
5
Dexamethasone as an antiemetic in patients treated with cisplatin.
N Engl J Med. 1981 Aug 27;305(9):520.
6
A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting.新型5HT3受体拮抗剂BRL43694A预防化疗引起的恶心和呕吐的I期研究。
Cancer Chemother Pharmacol. 1989;24(3):193-6. doi: 10.1007/BF00300242.
7
Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy.昂丹司琼（GR38032F）加地塞米松：对接受细胞毒性化疗的患者有效的止吐预防措施。
Br J Cancer. 1990 Feb;61(2):323-4. doi: 10.1038/bjc.1990.62.
Zotero 插件